Researchers at the Mayo Clinic campus in Florida have found that PKC-iota, an oncogene important in colon and lung cancers, is over-produced in PKC pancreatic cancer and is linked to poor patient survival.
They also found that in laboratory animals led to a significant decreaseigenetically inhibiting PKC in pancreatic tumor growth and spread.
Genetic Engineering & Biotechnology News, 2/24/2010
Tags: Cancer, oncogene, pancreatic cancer